Is Comprehensive Genomic Profiling Ready for Prime Time?
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
It is an exciting era for drug development in oncology. The many discoveries of new molecular targets, coupled with...
As we move slowly toward longer days and warmer temperatures, we bring you the latest round of highlighted articles...
For most solid tumors, traditional biopsies are the gold standard for diagnosing cancer and assessing molecular characteristics that may...
Guest post by Patrick Williams, PhDAACR Scientific Research Analyst In a virtual Congressional briefing on February 9, 2022, the...
For the first Editors’ Picks collection of 2022, the editors of the AACR journals highlighted studies that assessed the...
In the United States, advances in cancer research have dramatically improved outcomes for children diagnosed with cancer. While pediatric...
As recently as 10 years ago, the words “machine learning” evoked thoughts of sentient robots and fears of the...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
The new year brings a new chapter in the holy book of cancer biology with the publication in the...